In vitro activity of voriconazole against selected fungi
Affiliations
- PMID: 9776841
Item in Clipboard
In vitro activity of voriconazole against selected fungi
Med Mycol.
1998 Aug.
Abstract
Fifty-nine isolates consisting of 14 genera and 33 species of ascomycetes, basidiomycetes, and zygomycetes were tested against amphotericin B, fluconazole, itraconazole and voriconazole using an in vitro modified macrobroth dilution procedure based upon the NCCLS M27-A standard method for yeasts. The triazoles voriconazole and itraconazole had similar MIC values, except for Acremonium alabamensis, A. strictum, Fusarium oxysporum, F. solani and Wangiella dermatitidis, which had substantially lower voriconazole MIC values. Voriconazole MIC values were lower than those for itraconazole for the 17 species of Trichosporon tested. Fluconazole had high MIC values, often greater than 128 microg ml-1.
Similar articles
-
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15. doi: 10.1128/AAC.00163-06. Antimicrob Agents Chemother. 2006. PMID: 16723559 Free PMC article.
-
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.Int J Antimicrob Agents. 2008 Dec;32(6):511-4. doi: 10.1016/j.ijantimicag.2008.05.023. Epub 2008 Sep 13. Int J Antimicrob Agents. 2008. PMID: 18790613
-
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.J Clin Microbiol. 2001 Mar;39(3):954-8. doi: 10.1128/JCM.39.3.954-958.2001. J Clin Microbiol. 2001. PMID: 11230410 Free PMC article.
-
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.Mycopathologia. 2001;150(3):101-15. doi: 10.1023/a:1010954803886. Mycopathologia. 2001. PMID: 11469757 Review.
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
Cited by
-
Curvularia keratitis.Trans Am Ophthalmol Soc. 2001;99:111-30; discussion 130-2. Trans Am Ophthalmol Soc. 2001. PMID: 11797300 Free PMC article. Review.
-
Catheter associated urinary tract infections due to Trichosporon asahii.J Lab Physicians. 2018 Oct-Dec;10(4):464-470. doi: 10.4103/JLP.JLP_71_18. J Lab Physicians. 2018. PMID: 30498324 Free PMC article.
-
David and Goliath: chemical perturbation of eukaryotes by bacteria.J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):233-48. doi: 10.1007/s10295-015-1686-6. Epub 2015 Oct 3. J Ind Microbiol Biotechnol. 2016. PMID: 26433385 Free PMC article. Review.
-
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.Antimicrob Agents Chemother. 2006 Oct;50(10):3269-76. doi: 10.1128/AAC.00556-06. Antimicrob Agents Chemother. 2006. PMID: 17005804 Free PMC article.
-
Voriconazole in the management of nosocomial invasive fungal infections.Ther Clin Risk Manag. 2006 Jun;2(2):129-58. doi: 10.2147/tcrm.2006.2.2.129. Ther Clin Risk Manag. 2006. PMID: 18360588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical